The European Union attributes great importance for exploring new ways to overcome challenges to modern health care. Challenges represent: cancer, autoimmune diseases, degenerative diseases, infectious diseases, chronic diseases, viruses, and many others.

Basis for InnoMol is the combination of RBI resources and experts as well as networking infrastructures between work groups and Departments in order to create an innovative and productive research pipeline for the Molecular Biosciences.

As our goals are oriented to the future development of possible diagnostic, preventive and/or therapeutic approaches for the major diseases of the world, it is essential to have access to a centre of excellence that can provide the cross-functional and project-oriented alignment of resources and expertise along the value chain leading towards an innovative product.